Sumeyye Samur

Value Farm Consulting (Japan) — Japan

Medicine · Health Sciences

9h-index471citations43works0.72yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Liver Disease Diagnosis and Treatment(16), Hepatitis C virus research(11), Liver Disease and Transplantation(7), Health Systems, Economic Evaluations, Quality of Life(4), Hepatocellular Carcinoma Treatment and Prognosis(3)

Publications43 total

MSR65 Country-Specific Adaptation of Health Economic Models With Generative AI: A Case Study in Alzheimer’s Disease
Value in Health·2025
MSR188 Single-Agent vs. Multi-Agent RAG for Health Economic Model Replication: A Comparative Evaluation
Value in Health·2025
OP59 Exploring The Feasibility Of Generative Artificial Intelligence In Replicating Health Economic Models For Early-Phase Decision Support
International Journal of Technology Assessment in Health Care·2025Open Access
MSR52 Can Generative AI Automate Health Economic Model Verification?
Value in Health·2025
P60 Feasibility of Replicating a Published Health Economic Model From an ICER Report Using Generative AI
Value in Health·2025· 1 cited
MSR30 Evaluating Generative AI in Replicating Health Economic Models: A Case Study on Ulcerative Colitis
Value in Health·2025
MSR155 Assessing the Effectiveness of Large Language Models in Automating Systematic Literature Reviews: Findings from Recent Studies
Value in Health·2025
Enhancing recurrence detection in stage III colorectal cancer patients through molecular residual disease test-guided surveillance: A modeling study.
Journal of Clinical Oncology·2025
HTA326 Generative AI to Identify Comparative Critiques in HTA Reports From Multiple Countries
Value in Health·2024
HTA77 Replicating a Partitioned Survival Model From an ICER Report Using Generative AI
Value in Health·2024· 1 citedOpen Access
EE247 Fully Replicating Published Markov Health Economic Models Using Generative AI
Value in Health·2024· 2 citedOpen Access
P28 Development of De Novo Health Economic Models Using Generative AI
Value in Health·2024· 3 citedOpen Access
MSR84 Assessing the Performance of Large Language Models in Automating Systematic Literature Reviews: Insights From Recent Studies
Value in Health·2024Open Access
HTA240 Utilizing Generative AI Technology for Comprehensive HTA Report Analysis
Value in Health·2024
MSR44 How Accurate Are Large Language Models for Abstract Screening in Systematic Literature Reviews?
Value in Health·2024· 1 cited
EE355 Can Large Language Models Generate Conceptual Health Economic Models?
Value in Health·2024· 4 cited
P57 Clinical Outcomes of Low-Risk Stage II Colon Cancer Survivors Adhering to Guidelines: A Microsimulation Model
Value in Health·2024Open Access
P59 A Microsimulation Model for High-Risk Stage II and Stage III Colon Cancer Survivors Following the Current Guidelines
Value in Health·2024Open Access
EE508 Cost of Liver Cancer Screening in Patients with Cirrhosis
Value in Health·2023
Effectiveness of HCC surveillance programs using multitarget blood test: A modeling study
Hepatology Communications·2023· 5 citedOpen Access
page 1 of 3Next →

Frequent Co-authors

Jagpreet Chhatwal(33), Turgay Ayer(26), Emily D. Bethea(10), Chin Hur(8), Jasmeer P. Chhatwal(8), Lewis R. Roberts(6), Kathleen E. Corey(6), T Ermis(6), Raymond T. Chung(5), Özden O. Dalgıç(5), Mark S. Roberts(5), Ju Dong Yang(5), Mindie H. Nguyen(5), Neehar D. Parikh(5), Amit G. Singal(5), Işıl Yıldırım(5), Ismail Fatih Yildirim(5), Erol O. Gursel(5), Rachael Fleurence(5), Fasiha Kanwal(4)